Literature DB >> 12127567

Endophilin-1: a multifunctional protein.

Anne T Reutens1, C Glenn Begley.   

Abstract

Endophilin-1, a cytoplasmic Src homology 3 (SH3) domain-containing protein, localises in brain presynaptic nerve termini. Endophilin dimerises through its N-terminus, and participates at multiple stages in clathrin-coated endocytosis, from early membrane invagination to synaptic vesicle uncoating. Both its C-terminal SH3 domain and N-terminus are required for endocytosis. Through its SH3 domain, endophilin bound to proline-rich domains (PRDs) in other endocytic proteins, including synaptojanin and dynamin. The N-terminal region possesses unique functions affecting lipid membrane curvature, through lysophosphatidic acid acyl transferase (LPAAT) activity and direct binding and tubulating activity. In addition to synaptic vesicle formation, endophilin-1 complexes with signalling molecules, including cell surface receptors, metalloprotease disintegrins and germinal centre kinase-like kinase (GLK). Therefore, endophilin-1 may serve to couple vesicle biogenesis with intracellular signalling cascades. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127567     DOI: 10.1016/s1357-2725(02)00063-8

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  22 in total

1.  Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis.

Authors:  Chunjiang Fu; Gang Wu; Fenglin Lv; Feifei Tian
Journal:  J Mol Model       Date:  2011-09-27       Impact factor: 1.810

2.  Identification of endophilins 1 and 3 as selective binding partners for VGLUT1 and their co-localization in neocortical glutamatergic synapses: implications for vesicular glutamate transporter trafficking and excitatory vesicle formation.

Authors:  Stephanie De Gois; Elisabeth Jeanclos; Marie Morris; Sukhjeevan Grewal; Helene Varoqui; Jeffrey D Erickson
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

Review 3.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

4.  Endophilin isoforms have distinct characteristics in interactions with N-type Ca2+ channels and dynamin I.

Authors:  Qi Tian; Ji-Feng Zhang; Jinjin Fan; Zhihong Song; Yuan Chen
Journal:  Neurosci Bull       Date:  2012-07-13       Impact factor: 5.203

Review 5.  Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?

Authors:  Eva Borger; Laura Aitken; Heng Du; Wenshen Zhang; Frank J Gunn-Moore; Shirley Shi Du Yan
Journal:  Curr Alzheimer Res       Date:  2013-01       Impact factor: 3.498

6.  HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Authors:  Slava Rom; Marco Pacifici; Giovanni Passiatore; Susanna Aprea; Agnieszka Waligorska; Luis Del Valle; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2011-07-01

7.  Genetic modifiers of Drosophila palmitoyl-protein thioesterase 1-induced degeneration.

Authors:  Haley Buff; Alexis C Smith; Christopher A Korey
Journal:  Genetics       Date:  2007-04-03       Impact factor: 4.562

8.  Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

Authors:  Min Shi; Joshua Bradner; Theo K Bammler; David L Eaton; Jianpeng Zhang; ZuCheng Ye; Angela M Wilson; Thomas J Montine; Catherine Pan; Jing Zhang
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.

Authors:  Jeremy H Herskowitz; Andrea M Siegel; Meagan A Jacoby; Samuel H Speck
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

10.  Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.

Authors:  Matthias Voss; Marcus Lettau; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-10-06       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.